MIRM — Mirum Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $1.96bn
- $1.99bn
- $186.37m
- 52
- 14
- 88
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 117 | 232 | 157 | 152 | 286 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 3.27 | 24 | 68 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 119 | 236 | 167 | 190 | 388 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.73 | 3.24 | 2.55 | 2.35 | 1.99 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 147 | 241 | 295 | 353 | 647 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.1 | 18.5 | 42.6 | 64.7 | 87.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 16.4 | 68.8 | 174 | 211 | 398 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 130 | 172 | 120 | 142 | 249 |
Total Liabilities & Shareholders' Equity | 147 | 241 | 295 | 353 | 647 |
Total Common Shares Outstanding |